Correlation Between ISPIM and Tscan Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ISPIM and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ISPIM and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ISPIM 77 and Tscan Therapeutics, you can compare the effects of market volatilities on ISPIM and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ISPIM with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ISPIM and Tscan Therapeutics.

Diversification Opportunities for ISPIM and Tscan Therapeutics

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between ISPIM and Tscan is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding ISPIM 77 and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and ISPIM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ISPIM 77 are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of ISPIM i.e., ISPIM and Tscan Therapeutics go up and down completely randomly.

Pair Corralation between ISPIM and Tscan Therapeutics

Assuming the 90 days trading horizon ISPIM 77 is expected to generate 0.07 times more return on investment than Tscan Therapeutics. However, ISPIM 77 is 14.35 times less risky than Tscan Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  9,998  in ISPIM 77 on September 3, 2024 and sell it today you would lose (27.00) from holding ISPIM 77 or give up 0.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ISPIM 77  vs.  Tscan Therapeutics

 Performance 
       Timeline  
ISPIM 77 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ISPIM 77 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ISPIM is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Tscan Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Tscan Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

ISPIM and Tscan Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ISPIM and Tscan Therapeutics

The main advantage of trading using opposite ISPIM and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ISPIM position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.
The idea behind ISPIM 77 and Tscan Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon